Loading clinical trials...

Awareness, Care & Treatment In Obesity Management | Clinical Trials | Clareo Health

COMPLETED

Awareness, Care & Treatment In Obesity Management

Awareness, Care & Treatment In Obesity Management - An Observation in France

NCT05690789•Novo Nordisk A/S

Summary

ACTION France is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•People Living with Obesity
•1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
•2. Male or female, aged above or equal to 18 years at the time of signing informed consent Lives in France
•3. Current BMI based on self-reported height and weight of at least 30 kg/m\^2
•Health Care Professionals
•1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
•2. Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
•3. Physician with a license to practice
•4. Specialty is not surgeon (including bariatric or plastic surgeon)
•5. Practices in France
+12 more criteria

Exclusion Criteria

•People Living with obesity
•1. Previous participation in this study. Participation is defined as having given online consent in this study
•2. Currently pregnant
•3. Participates in intense fitness or body building programs
•4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
•5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
•Health Care Providers
•1. Previous participation in this study. Participation is defined as having given informed consent in this study.
•2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
•Employers
+2 more criteria

Locations (1)

Novo Nordisk Investigational Site

Puteaux, France

Key Dates

Start Date

September 27, 2022

Primary Completion Date

March 31, 2023

Completion Date

March 31, 2023

Last Updated

June 15, 2023

Enrollment

1,688

ACTUAL participants

Conditions

Obesity

Interventions

No treatment given

OTHER

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

RECRUITING

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454

Metabolic DiseaseObesity+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 15, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Awareness, Care & Treatment In Obesity Management

Inclusion Criteria

Exclusion Criteria

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

Protein Supplementation Intervention on Body Weight

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss